NRS
TMO icon

Neville Rodie & Shaw’s Thermo Fisher Scientific TMO Stock Holding History

Neville Rodie & Shaw’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6M Sell
55,115
-1,981
-3% -$951K 1.79% 14
2026
Q1 		$28.1M Buy
57,096
+210
+0.4% +$114K 2.04% 12
2025
Q4 		$33M Buy
56,886
+869
+2% +$491K 2.33% 11
2025
Q3 		$27.2M Sell
56,017
-9,504
-15% -$4.42M 1.96% 13
2025
Q2 		$26.6M Sell
65,521
-8,797
-12% -$3.68M 1.97% 11
2025
Q1 		$37M Sell
74,318
-4,522
-6% -$2.45M 2.9% 6
2024
Q4 		$41M Sell
78,840
-480
-0.6% -$264K 2.99% 5
2024
Q3 		$49.1M Sell
79,320
-3,597
-4% -$2.13M 3.61% 3
2024
Q2 		$45.9M Sell
82,917
-1,890
-2% -$1.08M 3.48% 4
2024
Q1 		$49.3M Buy
84,807
+312
+0.4% +$175K 3.76% 3
2023
Q4 		$44.9M Buy
84,495
+5
+0% +$2.42K 3.67% 3
2023
Q3 		$42.8M Sell
84,490
-505
-0.6% -$269K 3.81% 3
2023
Q2 		$44.3M Buy
84,995
+27
+0% +$14.6K 3.82% 3
2023
Q1 		$49M Sell
84,968
-2,074
-2% -$1.17M 4.44% 3
2022
Q4 		$47.9M Sell
87,042
-2,477
-3% -$1.31M 4.5% 2
2022
Q3 		$45.4M Sell
89,519
-288
-0.3% -$161K 4.46% 2
2022
Q2 		$48.8M Sell
89,807
-1,259
-1% -$693K 4.37% 2
2022
Q1 		$53.9M Sell
91,066
-1,017
-1% -$584K 4.01% 3
2021
Q4 		$61.4M Sell
92,083
-901
-1% -$563K 4.35% 3
2021
Q3 		$53.1M Sell
92,984
-553
-0.6% -$304K 4.13% 2
2021
Q2 		$47.2M Sell
93,537
-429
-0.5% -$202K 3.63% 4
2021
Q1 		$42.9M Sell
93,966
-6,004
-6% -$2.87M 3.55% 4
2020
Q4 		$46.6M Sell
99,970
-4,263
-4% -$2M 4.03% 3
2020
Q3 		$46M Sell
104,233
-802
-0.8% -$331K 4.34% 2
2020
Q2 		$38.1M Sell
105,035
-2,393
-2% -$802K 3.93% 4
2020
Q1 		$30.5M Sell
107,428
-1,362
-1% -$429K 3.71% 4
2019
Q4 		$35.3M Sell
108,790
-1,695
-2% -$514K 3.47% 3
2019
Q3 		$32.2M Buy
110,485
+372
+0.3% +$107K 3.41% 4
2019
Q2 		$32.3M Sell
110,113
-535
-0.5% -$147K 3.42% 4
2019
Q1 		$30.3M Sell
110,648
-1,204
-1% -$300K 3.21% 4
2018
Q4 		$25M Sell
111,852
-2,684
-2% -$630K 3.04% 4
2018
Q3 		$28M Buy
114,536
+1,965
+2% +$452K 2.76% 4
2018
Q2 		$23.3M Buy
112,571
+1,417
+1% +$301K 2.46% 4
2018
Q1 		$22.9M Sell
111,154
-2,101
-2% -$441K 2.53% 4
2017
Q4 		$21.5M Buy
113,255
+1,772
+2% +$339K 2.27% 4
2017
Q3 		$21.1M Sell
111,483
-2,680
-2% -$485K 2.35% 4
2017
Q2 		$19.9M Sell
114,163
-6,995
-6% -$1.17M 2.27% 4
2017
Q1 		$18.6M Sell
121,158
-6,234
-5% -$953K 2.13% 5
2016
Q4 		$18M Sell
127,392
-873
-0.7% -$129K 2.12% 4
2016
Q3 		$20.4M Sell
128,265
-940
-0.7% -$145K 2.4% 4
2016
Q2 		$19.1M Sell
129,205
-725
-0.6% -$107K 2.29% 4
2016
Q1 		$18.4M Sell
129,930
-824
-0.6% -$110K 2.24% 4
2015
Q4 		$18.5M Sell
130,754
-920
-0.7% -$123K 2.23% 4
2015
Q3 		$16.1M Sell
131,674
-3,912
-3% -$510K 1.97% 6
2015
Q2 		$17.6M Sell
135,586
-2,882
-2% -$376K 1.93% 6
2015
Q1 		$18.6M Sell
138,468
-3,197
-2% -$412K 1.93% 6
2014
Q4 		$17.7M Sell
141,665
-1,535
-1% -$187K 1.8% 7
2014
Q3 		$17.4M Buy
143,200
+973
+0.7% +$118K 1.72% 11
2014
Q2 		$16.8M Sell
142,227
-986
-0.7% -$116K 1.69% 11
2014
Q1 		$17.2M Sell
143,213
-4,095
-3% -$487K 1.86% 12
2013
Q4 		$16.4M Sell
147,308
-4,210
-3% -$419K 1.77% 11
2013
Q3 		$14M Buy
151,518
+2,440
+2% +$221K 1.63% 13
2013
Q2 		$12.6M Buy
+149,078
New +$12.4M 1.53% 14

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Neville Rodie & Shaw's TMO Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, selling an estimated $951K and leaving 55,115 shares worth $27.6M. The position accounts for 1.79% of the portfolio, ranked #14.

Neville Rodie & Shaw first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $61.4M in Q4 2021. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Neville Rodie & Shaw held 55,115 shares of Thermo Fisher Scientific worth $27.6M as of Q2 2026.
  • Neville Rodie & Shaw sold 1,981 Thermo Fisher Scientific shares in Q2 2026, an estimated $951K.
  • Thermo Fisher Scientific made up 1.79% of Neville Rodie & Shaw's portfolio in Q2 2026, its #14 holding.
  • Neville Rodie & Shaw first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Neville Rodie & Shaw's Thermo Fisher Scientific position peaked at $61.4M in Q4 2021.
  • 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.